In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling “network” makes a cancer cell resistant to a drug and selectively target them as well, say researchers.
In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling “network” makes a cancer cell resistant to a drug and selectively target them as well, say researchers.